Detalhe da pesquisa
1.
COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test.
Int J Infect Dis
; 122: 576-584, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35811081
2.
Computational modelling supports that dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity?
Comput Struct Biotechnol J
; 19: 459-466, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33391633
3.
Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests.
J Med Microbiol
; 70(6)2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110279
4.
Regarding: Masyeni S, Santoso MS, Widyaningsih PD, Wedha Asmara DG, Nainu F, Harapan H, et al. Serological cross-reaction and co-infection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2020;102:152-4. https://doi.org/10.1016/j.ijid.2020.10.043.
Int J Infect Dis
; 104: 737-738, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556608